Barclays PLC Kodiak Sciences Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Barclays PLC holds 79,658 shares of KOD stock, worth $440,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares

79,658

Previous 48,131 65.5%

Holding current value

$440,508

Previous $113,000 84.07%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$2.2 - $3.25 $69,359 - $102,462	31,527 Added 65.5%	79,658 $208,000
Q2 2024 Aug 14, 2024	SELL	$2.29 - $4.48 $25,847 - $50,565	-11,287 Reduced 19.0%	48,131 $113,000
Q1 2024 May 15, 2024	SELL	$3.01 - $7.45 $128,957 - $319,180	-42,843 Reduced 41.9%	59,418 $312,000
Q4 2023 Feb 15, 2024	BUY	$1.4 - $3.24 $54,427 - $125,961	38,877 Added 61.34%	102,261 $310,000
Q3 2023 Nov 07, 2023	BUY	$1.8 - $7.49 $50,117 - $208,544	27,843 Added 78.34%	63,384 $114,000
Q2 2023 Aug 03, 2023	SELL	$4.3 - $9.48 $41,538 - $91,576	-9,660 Reduced 21.37%	35,541 $245,000
Q1 2023 May 04, 2023	BUY	$4.81 - $8.88 $77,542 - $143,154	16,121 Added 55.44%	45,201 $280,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.05 $44,955 - $55,504	6,895 Added 31.08%	29,080 $208,000
Q3 2022 Nov 03, 2022	SELL	$7.57 - $12.5 $17,607 - $29,075	-2,326 Reduced 9.49%	22,185 $172,000
Q2 2022 Aug 12, 2022	BUY	$5.04 - $9.48 $51,665 - $97,179	10,251 Added 71.89%	24,511 $188,000
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $194,138 - $2.45 Million	-27,382 Reduced 65.76%	14,260 $110,000
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $2.18 Million - $3.47 Million	27,018 Added 184.75%	41,642 $3.53 Million
Q3 2021 Nov 09, 2021	BUY	$81.97 - $106.94 $773,141 - $1.01 Million	9,432 Added 181.66%	14,624 $1.4 Million
Q2 2021 Aug 13, 2021	SELL	$77.2 - $126.54 $3.48 Million - $5.7 Million	-45,032 Reduced 89.66%	5,192 $484,000
Q1 2021 May 13, 2021	SELL	$110.45 - $164.47 $5.04 Million - $7.5 Million	-45,622 Reduced 47.6%	50,224 $5.69 Million
Q4 2020 Feb 11, 2021	BUY	$60.78 - $154.03 $417,862 - $1.06 Million	6,875 Added 7.73%	95,846 $14.1 Million
Q3 2020 Nov 12, 2020	BUY	$45.05 - $59.27 $3.03 Million - $3.99 Million	67,249 Added 309.59%	88,971 $5.27 Million
Q2 2020 Aug 12, 2020	BUY	$42.74 - $66.25 $395,302 - $612,746	9,249 Added 74.15%	21,722 $1.18 Million
Q1 2020 May 13, 2020	SELL	$38.18 - $73.95 $562,735 - $1.09 Million	-14,739 Reduced 54.16%	12,473 $596,000
Q4 2019 Feb 10, 2020	BUY	$13.9 - $76.65 $147,812 - $815,096	10,634 Added 64.15%	27,212 $1.96 Million
Q3 2019 Nov 14, 2019	SELL	$10.24 - $17.57 $7,219 - $12,386	-705 Reduced 4.08%	16,578 $238,000
Q2 2019 Aug 14, 2019	BUY	$6.2 - $12.0 $90,520 - $175,200	14,600 Added 544.17%	17,283 $202,000
Q1 2019 May 15, 2019	BUY	$6.43 - $9.44 $17,251 - $25,327	2,683 New	2,683 $18,000

Others Institutions Holding KOD

# of Institutions

Shares Held

39M

Call Options Held

6.5K

Put Options Held

5.8K

View Full List

About Kodiak Sciences Inc.

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $288M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

More about KOD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account